Aprea Therapeutics
APRE
#10471
Rank
C$15.26 M
Marketcap
C$1.23
Share price
-2.69%
Change (1 day)
-48.26%
Change (1 year)

Earnings for Aprea Therapeutics (APRE)

Earnings in 2025 (TTM): -C$19.46 Million

According to Aprea Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$19.84 Million, an increase over its 2023 earnings that were of -C$21.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aprea Therapeutics from 2019 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$19.46 Million-1.88%
2024 -C$19.84 Million-7.45%
2023 -C$21.43 Million-58.6%
2022 -C$51.76 Million-0.2%
2021 -C$51.87 Million-29.09%
2020 -C$73.14 Million64.34%
2019 -C$44.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Magellan Health
MGLN
C$29.67 M-255.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
C$0.20 B-1,180.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
C$0.11 B-679.46%๐Ÿ‡บ๐Ÿ‡ธ USA